EGFR and breast carcinoma: The top 10 pathways were as follows: Chemical carcinogenesis-receptor activation, chemical carcinogenesis—ROS, proteoglycans in cancer, steroid hormone biosynthesis, endocrine resistance, ovarian steroidogenesis, EGFR tyrosine kinase inhibitor resistance, focal adhesion, the estrogen signaling pathway, and breast cancer.